Pamela Vig - 09 Jan 2023 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
CHIEF SCIENTIFIC OFFICER
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
09 Jan 2023
Transactions value $
-$28,438
Form type
4
Filing time
18 Mar 2024, 17:44:37 UTC
Previous filing
14 Nov 2022
Next filing
02 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Sale -$28.4K -1.38K -4.81% $20.62 27.3K 09 Jan 2023 Direct F1
holding MIRM Common Stock 75K 09 Jan 2023 By The Vig-Ancock Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to cover tax witholding obligations associated with the vesting of restricted stock units.